WHO 2021 data call is now open for both antibacterials and antifungals in the preclinical development pipeline

  07 October 2021

Opening date: 30 September 2021 at 12:00 Geneva time

Closing date: 30 October 2021 at 23:30 Geneva time

 
In January 2019 and 2020, the World Health Organization (WHO) released its first performed global reviews of the preclinical antibacterial pipeline, based on publicly available data primarily gathered through a WHO data call.

A 2020 update of the antibacterial preclinical data analyses report was performed and is available on the open source WHO Global Health R&D Observatory, and was published in the WHO Report 2020 antibacterial agents in clinical and preclinical development: an overview and analysis

WHO 2021 data call for antibacterial, and antifungal agents in preclinical development pipeline

WHO 2021 data call aims to collect data on:

  1. The 2021 update of WHO analysis and review antibacterial agents in the preclinical development pipeline. 
  2. The first WHO analysis of antifungal agents in the preclinical development pipeline.

The 2021 preclinical data analyses will feed into the WHO Global Health R&D Observatory. The analyses and data will be available for all stakeholders including existing and future funders of R&D. 

Further reading: WHO
Author(s): WHO
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed